These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 12389082
21. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]. Iñigo P, Lario S, Campistol JM, Bescós M, Campos B, Oppenheimer F. Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330 [Abstract] [Full Text] [Related]
23. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration. Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U. Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424 [Abstract] [Full Text] [Related]
24. Sex-associated differences in organ transplantation: different effects of steroid hormones, testosterone, estradiol, progesterone, and prednisolone on the survival time of allogeneic skin graft in rats treated with cyclosporin A. Hirasawa K, Enosawa S. Transplant Proc; 1991 Feb; 23(1 Pt 1):714-5. PubMed ID: 1990661 [Abstract] [Full Text] [Related]
32. C4d deposition is associated with chronic allograft nephropathy in rats and could be influenced by immunosuppressants. Yang L, Lu YP, Luo GH, Song J, Shi YJ, Li YP. Transplant Proc; 2008 Oct; 40(8):2782-5. PubMed ID: 18929861 [Abstract] [Full Text] [Related]
33. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. Transplant Proc; 2005 Oct; 37(1):134-6. PubMed ID: 15808572 [Abstract] [Full Text] [Related]
34. Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts. Pratschke J, Paz D, Wilhelm MJ, Laskowski I, Kofla G, Vergopoulos A, MacKenzie HJ, Tullius SG, Neuhaus P, Hancock WW, Volk HD, Tilney NL. Transplantation; 2004 Jan 15; 77(1):43-8. PubMed ID: 14724433 [Abstract] [Full Text] [Related]
35. Adenovirus-mediated antisense-ERK2 gene therapy attenuates chronic allograft nephropathy. Gong N, Dong C, Chen Z, Chen X, Guo H, Zeng Z, Ming C, Klaus Chen Z. Transplant Proc; 2006 Dec 15; 38(10):3228-30. PubMed ID: 17175230 [Abstract] [Full Text] [Related]
36. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy. Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP. Transplant Proc; 2008 Oct 15; 40(8):2804-7. PubMed ID: 18929866 [Abstract] [Full Text] [Related]
37. Effects of sex steroid hormones, estradiol and testosterone on the survival time of skin allografts in rats treated with total body irradiation. Hirasawa K. Transplant Proc; 1992 Aug 15; 24(4):1567-8. PubMed ID: 1496659 [No Abstract] [Full Text] [Related]
38. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection. Rintala SE, Savikko J, Rintala JM, von Willebrand E. Transplant Proc; 2006 Dec 15; 38(10):3236-8. PubMed ID: 17175233 [Abstract] [Full Text] [Related]
39. The effects of platelet-derived growth factor in rat cardiac allograft vasculopathy and fibrosis. Song G, Fang Y, Wang X, Wu S, Song H. Transplant Proc; 2008 Oct 15; 40(8):2716-9. PubMed ID: 18929844 [Abstract] [Full Text] [Related]
40. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model. Savikko J, von Willebrand E. Transplant Proc; 2006 Oct 15; 38(8):2699-700. PubMed ID: 17098043 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]